SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Denbury Inc. (DNRWW) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 66/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — DNRWW
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2013 |
$0.00 |
$2.49B |
$409.6M |
16.4% |
| 2014 |
$0.00 |
$2.42B |
$635.49M |
26.3% |
| 2015 |
$0.00 |
$1.24B |
$-4.39B |
-352.6% |
| 2016 |
$0.00 |
$960.57M |
$-976.18M |
-101.6% |
| 2017 |
$0.00 |
$1.12B |
$163.15M |
14.6% |
| 2018 |
$0.00 |
$1.45B |
$322.7M |
22.2% |
| 2019 |
$0.00 |
$1.26B |
$216.96M |
17.2% |
| 2020 |
$0.00 |
$714.16M |
$-1.49B |
-208.1% |
| 2021 |
$0.00 |
$1.24B |
$56M |
4.5% |
| 2022 |
$0.00 |
$1.7B |
$480.16M |
28.2% |
